Can sunscreen do more than protect? study tests if it fades dark spots

NCT ID NCT07679945

Recruiting now Symptom relief Sponsor: Kenvue Brands LLC Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether two types of facial sunscreen (untinted and tinted) can improve dark spots caused by melasma, sun spots, or post-inflammatory hyperpigmentation. Adult participants with mild to moderate dark spots apply the sunscreen at least twice daily for 56 days. Researchers measure changes in spot color and size using clinical evaluations, instruments, and photos, and also assess quality of life and participant satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: facial sunscreen (untinted and tinted)
What this could lead to: If effective, these sunscreens could offer a simple way to reduce dark spots and improve skin tone and quality of life.
What could go wrong: This is a small, open-label study without a placebo group, so results may be influenced by expectations. Effectiveness may vary by skin type and spot type.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELASMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperpigmentation lentigo Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELASMA POST-INFLAMMATORY HYPERPIGMENTATION SOLAR LENTIGO

Contacts and locations

Locations

ALS Beauty & Personal Care Ltda
RECRUITING

Campinas, São Paulo, 13084-791, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.